太平洋给予春立医疗“买入”评级：海外表现亮眼，盈利能力改善

Group 1 - The core viewpoint of the report is that Chuangli Medical (688236.SH) is rated as "Buy" due to improved profitability and competitive positioning [1] - The report highlights that the impact of centralized procurement has cleared, leading to enhanced profitability [1] - It notes that the company is making continuous progress in overseas market access, showcasing its global competitiveness [1] - The gross profit margin is stabilizing, and there has been a significant improvement in expense ratios [1]